{
  "description": "Test VCF containing CYP2C9 variants",
  "vcf_file": "test-cyp2c9-variants.vcf",
  "expected_outcomes": {
    "total_vcf_variants": 2,
    "pgx_variants_identified": 2,
    "pgx_variants_matched": 2,
    "pgx_variants_unmatched": 0,
    "detection_state": "pgx_variants_found_all_matched",
    "annotation_completeness": 1.0,
    "average_variant_quality": 39.95,
    "confidence_score_range": {
      "min": 0.82,
      "max": 0.95
    },
    "evidence_distribution": {
      "A": 2,
      "B": 0,
      "C": 0,
      "D": 0,
      "unknown": 0
    },
    "variants_by_gene": {
      "CYP2C9": 2
    },
    "variants_by_drug": {
      "warfarin": 2,
      "phenytoin": 2,
      "celecoxib": 2
    },
    "expected_variants": [
      {
        "rsid": "rs1799853",
        "gene": "CYP2C9",
        "star_allele": "*2",
        "chromosome": "10",
        "position": 94942290,
        "functional_status": "decreased",
        "evidence_level": "A",
        "biological_mechanism": "Reduced enzyme activity affecting warfarin metabolism, requiring lower doses"
      },
      {
        "rsid": "rs1057910",
        "gene": "CYP2C9",
        "star_allele": "*3",
        "chromosome": "10",
        "position": 94981296,
        "functional_status": "decreased",
        "evidence_level": "A",
        "biological_mechanism": "Significantly reduced enzyme activity with major impact on drug clearance"
      }
    ]
  }
}
